Cavo M - Search Results

1

Ruxolitinib- but not fedratinib-induced extreme thrombocytosis: the combination therapy with hydroxyurea and ruxolitinib is effective in reducing platelet count and splenomegaly/constitutional symptoms.

Polverelli N, Catani L, Vianelli N, Baccarani M, Cavo M, Palandri F. Polverelli N, et al. Among authors: cavo m. Ann Hematol. 2015 Sep;94(9):1585-7. doi: 10.1007/s00277-015-2397-9. Epub 2015 May 16. Ann Hematol. 2015. PMID: 25975976 No abstract available.

2

Prognostic variables and clinical staging in multiple myeloma.

Cavo M, Galieni P, Zuffa E, Baccarani M, Gobbi M, Tura S. Cavo M, et al. Blood. 1989 Oct;74(5):1774-80. Blood. 1989. PMID: 2790201 Free article.

3

High-dose melphalan for multiple myeloma.

Cavo M, Baccarani M, Gobbi M, Tura S. Cavo M, et al. Lancet. 1983 Nov 19;2(8360):1194. doi: 10.1016/s0140-6736(83)91240-0. Lancet. 1983. PMID: 6139546 No abstract available.

4

Plasma cell P170 expression and response to treatment in multiple myeloma.

Patriarca F, Melli C, Damiani D, Michieli M, Michelutti A, Cavo M, Baccarani M. Patriarca F, et al. Among authors: cavo m. Haematologica. 1996 May-Jun;81(3):232-7. Haematologica. 1996. PMID: 8767528 Clinical Trial.

5

Autoimmune mediated thrombocytopenia associated with the use of interferon-alpha in chronic myeloid leukemia.

Zuffa E, Vianelli N, Martinelli G, Tazzari P, Cavo M, Tura S. Zuffa E, et al. Among authors: cavo m. Haematologica. 1996 Nov-Dec;81(6):533-5. Haematologica. 1996. PMID: 9009441

6

Molecular remission after allogeneic or autologous transplantation of hematopoietic stem cells for multiple myeloma.

Martinelli G, Terragna C, Zamagni E, Ronconi S, Tosi P, Lemoli RM, Bandini G, Motta MR, Testoni N, Amabile M, Ottaviani E, Vianelli N, de Vivo A, Gozzetti A, Tura S, Cavo M. Martinelli G, et al. Among authors: cavo m. J Clin Oncol. 2000 Jun;18(11):2273-81. doi: 10.1200/JCO.2000.18.11.2273. J Clin Oncol. 2000. PMID: 10829048

7

Salvage therapy with thalidomide in multiple myeloma patients relapsing after autologous peripheral blood stem cell transplantation.

Tosi P, Ronconi S, Zamagni E, Cellini C, Grafone T, Cangini D, Pileri SA, Baccarani M, Tura S, Cavo M. Tosi P, et al. Among authors: cavo m. Haematologica. 2001 Apr;86(4):409-13. Haematologica. 2001. PMID: 11325648 Clinical Trial.

8

Salvage therapy with thalidomide in patients with advanced relapsed/refractory multiple myeloma.

Tosi P, Zamagni E, Cellini C, Ronconi S, Patriarca F, Ballerini F, Musto P, Di Raimondo F, Ledda A, Lauria F, Masini L, Gobbi M, Vacca A, Ria R, Cangini D, Tura S, Baccarani M, Cavo M. Tosi P, et al. Among authors: cavo m. Haematologica. 2002 Apr;87(4):408-14. Haematologica. 2002. PMID: 11940485 Clinical Trial.

9

Melphalan-prednisone versus alternating combination VAD/MP or VND/MP as primary therapy for multiple myeloma: final analysis of a randomized clinical study.

Cavo M, Benni M, Ronconi S, Fiacchini M, Gozzetti A, Zamagni E, Cellini C, Tosi P, Baccarani M, Tura S; Writing Committee of the "Bologna 90" Clinical Trial. Cavo M, et al. Haematologica. 2002 Sep;87(9):934-42. Haematologica. 2002. PMID: 12217805 Clinical Trial.

10

Novel mutation and RNA splice variant of fibroblast growth factor receptor 3 in multiple myeloma patients at diagnosis.

Soverini S, Terragna C, Testoni N, Ruggeri D, Tosi P, Zamagni E, Cellini C, Cavo M, Baccarani M, Tura S, Martinelli G. Soverini S, et al. Among authors: cavo m. Haematologica. 2002 Oct;87(10):1036-40. Haematologica. 2002. PMID: 12368157

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

635 results

Search Page

Filters